Former Prime Minister and Dr. Michael R. Hayden to be honoured at Rx&D
Health Research Foundation and Prix Galien Canada Gala
MONTREAL, Oct. 29 /CNW/ - On November 15, 2007 the Rx&D Health Research
Foundation will bestow former Prime Minister Brian Mulroney with its
rarely-awarded Medal of Honour, an exceptional award given to recognize a
significant contribution to health sciences.
"The Health Research Foundation is proud to give this prestigious award
to the Right Honourable Brian Mulroney," said Dr. Yves Morin, Chair of the
Rx&D Health Research Foundation. "His contributions to Canada's health care
system and his commitment to investments in health sciences research and
development were the fundamental reasons the Foundation wanted to honour him
with this special recognition."
The Prix Galien will be given to Dr. Michael R. Hayden, Director and
Senior Scientist, Centre for Molecular Medicine and Therapeutics, University
of British Columbia. Dr. Hayden is also the Canada Research Chair in Human
Genetics and Molecular Medicine, University Killam Professor, Department of
Medical Genetics, University of British Columbia.
"Dr. Michael R. Hayden is truly one of Canada's most outstanding
scientists," said Dr. Jacques Gagné, Prix Galien Canada Jury Chairman. "Dr.
Hayden's career has been truly exceptional and his key discoveries have
prompted significant advances in several fields, such as his research on
Huntington's disease and his role in the pharmacogenomics analysis of severe
adverse drug reactions in children."
This year's recipient of the Belleau-Nickerson Award will also be
announced during the Gala.
About The Rx&D Health Research Foundation (HRF):
The Rx&D Health Research Foundation is a non-profit organization whose
mission is to support health research in Canadian academic health centres and
promote the value of health research in Canada. By applying the highest
standards of scientific excellence, addressing health challenges and
establishing partnerships, HRF, one of the leading private health foundations
in the country, contributes significantly to the prevention and treatment of
disease, to a better health care system and the availability for Canadians to
access effective health products.
About The Prix Galien:
The Prix Galien was established in 1970 by Roland Mehl, a French
pharmacist. It has subsequently acquired such fame that several other European
countries have adopted it. In 1994, Canada joined the European group with the
collaboration of Dr. Jacques Gagné, making Canada the first North American
country to give this award. The Prix Galien's objectives are to acknowledge
and promote pharmaceutical research and innovation. Prix Galien is considered
the Nobel Prize for the biopharmaceutical innovation world.
About The Belleau-Nickerson Award:
The Belleau-Nickerson Award is a unique Canadian award named after two
eminent researchers who left their mark on pioneering research in Canada: the
late Dr. Bernard Belleau and the late Dr. Mark Nickerson. The
Belleau-Nickerson Awardee is selected by a jury of the Deans of the Faculties
of Pharmacy in Canada to emphasize the therapeutic, social and economic
contribution of a drug product marketed in the last decade.
For further information:
For further information: Mylène Dupéré, Thornley Fallis Communications,
(613) 231-3355 ext. 223, email@example.com